These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9427537)

  • 1. High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.
    Patrick SM; Henkels KM; Turchi JJ
    Biochim Biophys Acta; 1997 Nov; 1354(3):279-90. PubMed ID: 9427537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bound Lac repressor protein differentially inhibits the unwinding reactions catalyzed by DNA helicases.
    Yancey-Wrona JE; Matson SW
    Nucleic Acids Res; 1992 Dec; 20(24):6713-21. PubMed ID: 1336182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-DNA binding specificity of calf high-mobility group 1 protein.
    Turchi JJ; Li M; Henkels KM
    Biochemistry; 1996 Mar; 35(9):2992-3000. PubMed ID: 8608137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA substrate specificity of DNA helicase E from calf thymus.
    Turchi JJ; Murante RS; Bambara RA
    Nucleic Acids Res; 1992 Nov; 20(22):6075-80. PubMed ID: 1334262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.
    Patrick SM; Turchi JJ
    Biochemistry; 1998 Jun; 37(24):8808-15. PubMed ID: 9628743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of calf thymus DNA helicase E on cis-diamminedichloroplatinum (II)-damaged DNA.
    Huang L; Turchi JJ; Wahl AF; Bambara RA
    J Biol Chem; 1993 Dec; 268(35):26731-7. PubMed ID: 8253808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repair of cisplatin--DNA adducts by the mammalian excision nuclease.
    Zamble DB; Mu D; Reardon JT; Sancar A; Lippard SJ
    Biochemistry; 1996 Aug; 35(31):10004-13. PubMed ID: 8756462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA.
    Lawrence DL; Engelsberg BN; Farid RS; Hughes EN; Billings PC
    J Biol Chem; 1993 Nov; 268(32):23940-5. PubMed ID: 8226934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of platinum-induced DNA damage by nuclear proteins: screening for mechanisms.
    Marples B; Adomat H; Billings PC; Farrell NP; Koch CJ; Skov KA
    Anticancer Drug Des; 1994 Oct; 9(5):389-99. PubMed ID: 7945723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
    Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
    Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism.
    Locker D; Decoville M; Maurizot JC; Bianchi ME; Leng M
    J Mol Biol; 1995 Feb; 246(2):243-7. PubMed ID: 7869375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Rad3 DNA helicase activity by DNA adducts and abasic sites: implications for the role of a DNA helicase in damage-specific incision of DNA.
    Naegeli H; Bardwell L; Friedberg EC
    Biochemistry; 1993 Jan; 32(2):613-21. PubMed ID: 8380702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of mammalian proteins with cisplatin-damaged DNA.
    Turchi JJ; Henkels KM; Hermanson IL; Patrick SM
    J Inorg Biochem; 1999 Oct; 77(1-2):83-7. PubMed ID: 10626358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG domain proteins induce sharp bends in cisplatin-modified DNA.
    Chow CS; Whitehead JP; Lippard SJ
    Biochemistry; 1994 Dec; 33(50):15124-30. PubMed ID: 7999772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2.
    Hughes EN; Engelsberg BN; Billings PC
    J Biol Chem; 1992 Jul; 267(19):13520-7. PubMed ID: 1618852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
    Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA.
    Turchi JJ; Patrick SM; Henkels KM
    Biochemistry; 1997 Jun; 36(24):7586-93. PubMed ID: 9200710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
    Huang JC; Zamble DB; Reardon JT; Lippard SJ; Sancar A
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10394-8. PubMed ID: 7937961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin.
    Yarnell AT; Oh S; Reinberg D; Lippard SJ
    J Biol Chem; 2001 Jul; 276(28):25736-41. PubMed ID: 11344167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1.
    Hill DA; Pedulla ML; Reeves R
    Nucleic Acids Res; 1999 May; 27(10):2135-44. PubMed ID: 10219086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.